Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years.
Omerovic E, James S, Råmundal T, Fröbert O, Linder R, Danielewicz M, Hamid M, Pagonis C, Henareh L, Wagner H, Stewart J, Jensen J, Lindros P, Robertsson L, Wikström H, Ulvenstam A, Bhiladval P, Tödt T, Ioanes D, Kellerth T, Zagozdzon L, Götberg M, Andersson J, Angerås O, Östlund O, Held C, Koul S, Erlinge D.
Omerovic E, et al. Among authors: andersson j.
Cardiovasc Revasc Med. 2024 Mar 26:S1553-8389(24)00113-1. doi: 10.1016/j.carrev.2024.03.025. Online ahead of print.
Cardiovasc Revasc Med. 2024.
PMID: 38575449